05/01/2019

WHO health economist Dr. Raymond Hutubessy addresses ‘The Full Public Health Value of Vaccines’ at IVI Seminar

Dr. Raymond Hutubessy with Dr. Vittal Mogasale, Head of IVI’s Policy & Economic Research Department   On April 29, IVI welcomed Dr. Raymond Hutubessy, Senior Economist from the Immunization, Vaccines and Biologicals (IVB), Initiative for Vaccine Research (IVR) at the World Health Organization Headquarters, in Geneva, Switzerland, as […]
05/08/2019

IVI hosts Environmental Impact Assessment Workshop

  As part of IVI’s commitment to environmental protection and combating climate change, IVI hosted an Environmental Impact Assessment workshop with the Swedish consultants Goodpoint on May 7, 2019. IVI and Goodpoint are working together on the development of an IVI environmental management plan.  
05/10/2019

IVI scientists’ paper recommended by Faculty of 1000 Biology, and Korea’s bioscience portal

Dr. Manki Song, Acting Deputy Director General of Science   Dr. Manki Song, Acting Deputy Director General of Science, Dr. Jae Seung Yang, Senior Scientist, and Ms. Eun Young Lee, Researcher at IVI, and others’ manuscript “Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, […]
05/15/2019

Former KSC Vice President Ms. Joanne Lee donates 50 million KRW to IVI

  Ms. Joanne Lee, former Vice President of the Korea Support Committee for IVI and former Chairperson of the IVI Fundraising Campaign Committee (2005-2006), donated 50 million KRW (US$42,000) via KSC to support IVI’s vaccine research and development. Ms. Lee, who is currently based in […]